Developing Highly Sensitive, High Throughput Methodologies to Perform Time & Cost-Effective Proteomics Analysis to Support Drug Discovery at Scale

8:00 am - Wednesday 4th February 2026

  • Achieving proteomics workflows at an unprecedented scale with optimized analysis methodologies
  • Balancing coverage, throughput, and sensitivity of proteomic platforms to accurately analyze the proteome, including low-abundance proteins
  • Exploring data showing how proteomics can transform drug discovery and unlock otherwise undruggable targets

Speakers:

Director
Johnson & Johnson